Systematic evaluation of the efficacy‐effectiveness gap of systemic treatments in extensive disease small cell lung cancer
Sign Up to like & getrecommendations! Published in 2020 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.5179
Abstract: The aim of this study is to assess how clinical outcomes in real‐world (effectiveness) correspond to the outcomes in clinical trials (efficacy) of systemic treatments for extensive disease small cell lung cancer (ED SCLC). read more here.
Keywords: treatments extensive; cell lung; extensive disease; disease small ... See more keywords
Prophylactic cranial irradiation in extensive disease small cell lung cancer: An endless debate.
Sign Up to like & getrecommendations! Published in 2019 at "Critical reviews in oncology/hematology"
DOI: 10.1016/j.critrevonc.2019.08.010
Abstract: Extensive disease Small cell lung cancer (ED-SCLC) represents a very aggressive malignancy in which brain metastases (BM) are quite common. Clinical trials on prophylactic cranial irradiation (PCI) have showed a clear decrease in the risk… read more here.
Keywords: cell lung; extensive disease; disease small; cancer ... See more keywords
Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Management and Research"
DOI: 10.2147/cmar.s180990
Abstract: Background Systemic inflammation appears to play a role in the progression of numerous solid tumors by promoting tumor proliferation. Our current study aimed to evaluate the role of inflammatory markers in limited disease (LD) small-cell… read more here.
Keywords: cell lung; disease small; cancer; inflammatory markers ... See more keywords
Adherence to recommended clinical guidelines in extensive disease small-cell lung cancer across the US, Europe, and Japan
Sign Up to like & getrecommendations! Published in 2019 at "Therapeutics and Clinical Risk Management"
DOI: 10.2147/tcrm.s183216
Abstract: Purpose This study compared real-world treatment patterns of patients with extensive disease small-cell lung cancer (ED-SCLC) across regions and by platinum resistance/platinum sensitivity (PR/PS) and established if these patterns were in line with published guidelines.… read more here.
Keywords: disease small; treatment; oncology; platinum ... See more keywords
Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement.
Sign Up to like & getrecommendations! Published in 2018 at "Anticancer research"
DOI: 10.21873/anticanres.12296
Abstract: BACKGROUND/AIM There are several definitions of limited disease (LD) in small cell lung cancer (SCLC), differing with respect to N3 disease accepted. We analyzed patients from a randomized trial comparing two schedules of thoracic radiotherapy… read more here.
Keywords: disease; cell lung; disease small; lung cancer ... See more keywords
Treatment Outcomes of 9,994 Patients With Extensive-Disease Small-Cell Lung Cancer From a Retrospective Nationwide Population-Based Cohort in the Korean HIRA Database
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.546672
Abstract: To investigate the efficacy of irinotecan-based (IP) and etoposide-based (EP) platinum combinations, and of single-agent chemotherapy, for treatment of extensive-disease small cell lung cancer (ED-SCLC), we performed a large-scale, retrospective, nationwide, cohort study. The population… read more here.
Keywords: treatment; small cell; extensive disease; disease small ... See more keywords